NORMAN SWAN: Another potential risk is cancer from the growth factors being turned on in Greg Fahy's treatment
Related research peptides available at FillerSupplies.com: BPC-157, TB-500, KPV
It may help cancer-related cachexia by reducing proteasome activity (50) , but studies in humans are needed
Pre-Research Assessment: Complete medical history and physical review Baseline blood glucose and HbA1c Liver function tests (ALT, AST, bilirubin) Renal function tests (creatinine, BUN, eGFR) Complete blood count Lipid panel IGF-1 and IGFBP-3 levels Thyroid function tests Screening for contraindications During Research Tracking: Regular blood glucose tracking (frequency based on dose and risk factors) Periodic assessment of liver and renal function Tracking for signs of fluid retention Assessment of injection sites Records of any adverse findings Regular evaluation of research parameters Post-Research Assessment: Repeat baseline laboratory tests Evaluation of any persistent effects Assessment of research outcomes Planning of appropriate follow-up Managing Adverse Observations Research protocols should include plans for managing possible adverse findings
If this occurs, seek emergency care immediately
As regards diabetic neuropathy, up to 50% of patients with diabetes have diabetic peripheral neuropathy (DPN), which is a significant contributor to morbidity and higher death rates
